Press Releases  (View all Press Releases)

Boston, MA - January 25, 2008
PAREXEL Hits New Peak Market Cap of $1.6 Billion
A. Dana Callow, Jr. is pleased to highlight that, as a result of the company’s better-than-expected fiscal 2nd-quarter results, shares of Parexel International Corporation (PRXL) traded at an all time high on January 24, 2008, reaching a peak price of $58.38 and a market value of over $1.6 billion.

Cumberland, RI - April 10, 2008
Collegium's Partner, BTG, Reports Positive Results from First Study Investigating BGC20-0166 in Obstructive Sleep Apnea Patients
Collegium announced that its licensing partner, BTG, reports positive results from the clinical proof of concept study of BGC20-0166, a combination of two marketed drugs for the treatment of obstructive sleep apnea syndrome.

Cumberland, RI - April 8, 2008
Collegium Pharmaceutical Announces FDA Filing for AllerNase™, a Nasal Inhaled Steroid for the Treatment of Allergic Rhinitis
Collegium announced that it filed a Supplemental New Drug Application with the FDA for the approval of AllerNase™ Nasal Spray, an aqueous based intranasal steroid indicated for the once daily treatment of nasal symptoms associated with both seasonal and perennial allergic rhinitis.

Boston, MA - December 2, 2006
Jean-Yves Lagarde Panelist at 9th Annual MIT Venture Capital Conference
Jean-Yves Lagarde was one of six panelists discussing "Commercializing Web 2.0 – Hype vs. Reality" at the 9th Annual MIT Venture Capital Conference

April 11, 2006
Jobs for Massachusetts Council
Dana Callow, member and presenter to Jobs for Massachusetts Council comprised of the Governor of Massachusetts and many state and business leaders in Boston.

April 4, 2006
Dana Callow Presented at the Invention to Venture Life Sciences Forum at the Harvard Medical School
Dana Callow presented at the Invention to Venture Life Sciences Forum.